JP2011526785A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011526785A5 JP2011526785A5 JP2011516790A JP2011516790A JP2011526785A5 JP 2011526785 A5 JP2011526785 A5 JP 2011526785A5 JP 2011516790 A JP2011516790 A JP 2011516790A JP 2011516790 A JP2011516790 A JP 2011516790A JP 2011526785 A5 JP2011526785 A5 JP 2011526785A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- antibody
- binding fragment
- seq
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7704108P | 2008-06-30 | 2008-06-30 | |
| US61/077,041 | 2008-06-30 | ||
| US9703408P | 2008-09-15 | 2008-09-15 | |
| US61/097,034 | 2008-09-15 | ||
| PCT/US2009/049139 WO2010002822A1 (en) | 2008-06-30 | 2009-06-30 | Anti-gd2 antibodies and methods and uses related thereto |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011526785A JP2011526785A (ja) | 2011-10-20 |
| JP2011526785A5 true JP2011526785A5 (https=) | 2012-08-16 |
| JP5654986B2 JP5654986B2 (ja) | 2015-01-14 |
Family
ID=41139062
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011516790A Expired - Fee Related JP5654986B2 (ja) | 2008-06-30 | 2009-06-30 | 抗ｇｄ２抗体並びにそれに関連する方法及び使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US8278065B2 (https=) |
| EP (1) | EP2310416A1 (https=) |
| JP (1) | JP5654986B2 (https=) |
| KR (1) | KR20110025859A (https=) |
| CN (1) | CN102164962B (https=) |
| AU (1) | AU2009267113A1 (https=) |
| CA (1) | CA2729499A1 (https=) |
| IL (1) | IL210147A0 (https=) |
| MX (1) | MX2010014364A (https=) |
| TW (1) | TWI466684B (https=) |
| WO (1) | WO2010002822A1 (https=) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102164962B (zh) | 2008-06-30 | 2014-05-28 | 诺福泰克公司 | 抗gd2抗体和方法及其相关应用 |
| WO2013189516A1 (en) | 2012-06-18 | 2013-12-27 | Apeiron Biologics Ag | Method for treating a gd2 positive cancer |
| EP2925783B1 (en) | 2012-11-30 | 2020-07-29 | Katinger GmbH | Recombinant human igm-antibody effective against cancer cells |
| SG11201600853UA (en) | 2013-08-05 | 2016-03-30 | Twist Bioscience Corp | De novo synthesized gene libraries |
| US10447673B2 (en) * | 2013-08-05 | 2019-10-15 | Sony Corporation | Information processing apparatus, information processing method, and computer program |
| ES2768649T3 (es) | 2013-11-21 | 2020-06-23 | Apeiron Biologics Ag | Preparaciones para tratar un cáncer positivo para GD2 |
| US9840566B2 (en) | 2013-11-21 | 2017-12-12 | Apeiron Biologics Ag | Preparations and methods for treating a GD2 positive cancer |
| CA2971151C (en) * | 2014-01-09 | 2020-10-27 | Kentucky Bioprocessing, Inc. | Method of purifying monoclonal antibodies |
| ES2866935T3 (es) | 2014-01-10 | 2021-10-20 | Anaptysbio Inc | Anticuerpos dirigidos contra interleucina-33 (IL-33) |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| US10669304B2 (en) | 2015-02-04 | 2020-06-02 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
| US9981239B2 (en) | 2015-04-21 | 2018-05-29 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US10294306B2 (en) * | 2015-05-28 | 2019-05-21 | Bio-Rad Laboratories, Inc. | Affinity ligands and methods relating thereto |
| EP3350314A4 (en) | 2015-09-18 | 2019-02-06 | Twist Bioscience Corporation | OLIGONUCLEIC ACID VARIANT LIBRARIES VARIANT AND SYNTHESIS THEREOF |
| KR102794025B1 (ko) | 2015-09-22 | 2025-04-09 | 트위스트 바이오사이언스 코포레이션 | 핵산 합성을 위한 가요성 기판 |
| PL3368571T3 (pl) | 2015-10-30 | 2023-05-02 | The Regents Of The University Of California | Polipeptydy odpowiadające na transformujący czynnik wzrostu beta i sposoby ich zastosowania |
| US10417457B2 (en) | 2016-09-21 | 2019-09-17 | Twist Bioscience Corporation | Nucleic acid based data storage |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| EP4556433A3 (en) | 2017-02-22 | 2025-08-06 | Twist Bioscience Corporation | Nucleic acid based data storage |
| WO2018231872A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
| US11407837B2 (en) | 2017-09-11 | 2022-08-09 | Twist Bioscience Corporation | GPCR binding proteins and synthesis thereof |
| CN111565834B (zh) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | 用于多核苷酸合成的加热的纳米孔 |
| KR102804057B1 (ko) | 2018-01-04 | 2025-05-07 | 트위스트 바이오사이언스 코포레이션 | Dna 기반 디지털 정보 저장 |
| CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
| WO2020139871A1 (en) | 2018-12-26 | 2020-07-02 | Twist Bioscience Corporation | Highly accurate de novo polynucleotide synthesis |
| CN113766930B (zh) | 2019-02-26 | 2025-07-22 | 特韦斯特生物科学公司 | Glp1受体的变异核酸文库 |
| JP2022522668A (ja) | 2019-02-26 | 2022-04-20 | ツイスト バイオサイエンス コーポレーション | 抗体を最適化するための変異体核酸ライブラリ |
| CN114096240A (zh) | 2019-05-17 | 2022-02-25 | 癌症预防制药股份有限公司 | 用于治疗家族性腺瘤性息肉病的方法 |
| US12410238B2 (en) | 2019-06-19 | 2025-09-09 | Icahn School Of Medicine At Mount Sinai | Monoclonal antibodies against JC virus |
| US11332738B2 (en) | 2019-06-21 | 2022-05-17 | Twist Bioscience Corporation | Barcode-based nucleic acid sequence assembly |
| EP4008347B1 (en) * | 2019-08-01 | 2025-04-30 | Mie University | GD2-BINDING MOLECULE |
| EP4034566A4 (en) | 2019-09-23 | 2024-01-24 | Twist Bioscience Corporation | VARIANT NUCLEIC ACID BANKS FOR CRTH2 |
| JP2022548783A (ja) | 2019-09-23 | 2022-11-21 | ツイスト バイオサイエンス コーポレーション | 単一ドメイン抗体のバリアント核酸ライブラリー |
| BR112022011235A2 (pt) | 2019-12-09 | 2022-12-13 | Twist Bioscience Corp | Bibliotecas de variantes de ácido nucleico para receptores de adenosina |
| CN114685658B (zh) * | 2020-12-30 | 2024-12-17 | 百力司康生物医药(杭州)有限公司 | Ox40的靶向抗体及其制备方法和应用 |
| KR20230147617A (ko) | 2021-01-21 | 2023-10-23 | 트위스트 바이오사이언스 코포레이션 | 아데노신 수용체에 관한 방법 및 조성물 |
| TW202302648A (zh) * | 2021-03-12 | 2023-01-16 | 美商健生生物科技公司 | Cd79b抗體於自體免疫治療應用之用途 |
| WO2024040194A1 (en) | 2022-08-17 | 2024-02-22 | Capstan Therapeutics, Inc. | Conditioning for in vivo immune cell engineering |
| AU2024279278A1 (en) | 2023-05-31 | 2025-12-18 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| US20250127728A1 (en) | 2023-10-05 | 2025-04-24 | Capstan Therapeutics, Inc. | Constrained Ionizable Cationic Lipids and Lipid Nanoparticles |
| WO2025076113A1 (en) | 2023-10-05 | 2025-04-10 | Capstan Therapeutics, Inc. | Ionizable cationic lipids with conserved spacing and lipid nanoparticles |
| WO2025149667A1 (en) | 2024-01-12 | 2025-07-17 | Pheon Therapeutics Ltd | Antibody drug conjugates and uses thereof |
| WO2025217452A1 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Constrained ionizable cationic lipids and lipid nanoparticles |
| WO2025217454A2 (en) | 2024-04-11 | 2025-10-16 | Capstan Therapeutics, Inc. | Ionizable cationic lipids and lipid nanoparticles |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5419904A (en) * | 1990-11-05 | 1995-05-30 | The Regents Of The University Of California | Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
| WO1993010221A1 (en) | 1991-11-13 | 1993-05-27 | The Regents Of The University Of California | Chimeric murine/human anti-idiotype monoclonal antibodies |
| US6309636B1 (en) * | 1995-09-14 | 2001-10-30 | Cancer Research Institute Of Contra Costa | Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides |
| WO1997034634A1 (en) | 1996-03-20 | 1997-09-25 | Sloan-Kettering Institute For Cancer Research | Single chain fv constructs of anti-ganglioside gd2 antibodies |
| AU725329B2 (en) * | 1996-09-02 | 2000-10-12 | Ko Okumura | Humanized immunoglobulin reacting specifically with Fas ligand or active fragments thereof and region inducing apoptosis originating in Fas ligand |
| WO2004055056A1 (en) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | Humanized antibody (h14.18) of the mouse 14.18 antibody binding to gd2 and its fusion with il-2 |
| DE602004030451D1 (de) * | 2003-07-15 | 2011-01-20 | Chugai Pharmaceutical Co Ltd | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion |
| FR2906808B1 (fr) * | 2006-10-10 | 2012-10-05 | Univ Nantes | Utilisation d'anticorps monoclonaux specifiques de la forme o-acetylee du ganglioside gd2 dans le traitement de certains cancers |
| CN102164962B (zh) | 2008-06-30 | 2014-05-28 | 诺福泰克公司 | 抗gd2抗体和方法及其相关应用 |
-
2009
- 2009-06-30 CN CN200980132087.5A patent/CN102164962B/zh not_active Expired - Fee Related
- 2009-06-30 WO PCT/US2009/049139 patent/WO2010002822A1/en not_active Ceased
- 2009-06-30 JP JP2011516790A patent/JP5654986B2/ja not_active Expired - Fee Related
- 2009-06-30 MX MX2010014364A patent/MX2010014364A/es active IP Right Grant
- 2009-06-30 TW TW98122129A patent/TWI466684B/zh not_active IP Right Cessation
- 2009-06-30 AU AU2009267113A patent/AU2009267113A1/en not_active Abandoned
- 2009-06-30 CA CA2729499A patent/CA2729499A1/en not_active Abandoned
- 2009-06-30 US US12/494,631 patent/US8278065B2/en not_active Expired - Fee Related
- 2009-06-30 KR KR1020117002248A patent/KR20110025859A/ko not_active Withdrawn
- 2009-06-30 EP EP09774273A patent/EP2310416A1/en not_active Withdrawn
-
2010
- 2010-12-21 IL IL210147A patent/IL210147A0/en unknown
-
2012
- 2012-08-23 US US13/593,057 patent/US8507657B2/en not_active Expired - Fee Related
-
2013
- 2013-07-02 US US13/933,594 patent/US8956832B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011526785A5 (https=) | ||
| CN110799539B (zh) | 抗4-1bb抗体及其制备和使用方法 | |
| JP2021524267A5 (https=) | ||
| CN110914304B (zh) | Cd96抗体、其抗原结合片段及医药用途 | |
| JP2014526898A5 (https=) | ||
| RU2014131317A (ru) | Связывающие mica агенты | |
| TW201708261A (zh) | Ｄｌｌ３及ｃｄ３抗體構築體 | |
| WO2015032906A4 (en) | Cd70-binding peptides and method, process and use relating thereto | |
| TW201915026A (zh) | Ｔｉｇｉｔ抗體、其抗原結合片段及醫藥用途 | |
| JP2022514693A5 (https=) | ||
| NZ610734A (en) | Human antibodies to the glucagon receptor | |
| FI3592769T3 (fi) | Vasta-aineita PD-L1:tä vastaan | |
| JP2014534242A5 (https=) | ||
| FI3922645T3 (fi) | Pro-/latentin myostatiinin vasta-aineita ja niiden käyttötapoja | |
| IL290591B1 (en) | Antibody drug conjugates (adc) that bind to 191p4d12 proteins | |
| JP2018527919A5 (https=) | ||
| JP2019534892A5 (https=) | ||
| JP2013538057A5 (https=) | ||
| JP2012509881A5 (https=) | ||
| NZ602892A (en) | Antibodies that bind human cd27 and uses thereof | |
| NZ597067A (en) | Monoclonal antibodies expressed by ATCC PTA-4621 for the treatment of cancer | |
| JP2011509245A5 (https=) | ||
| JP2011510654A5 (https=) | ||
| JP2014524733A5 (https=) | ||
| JP2010533498A5 (https=) |